3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tooth, Impacted
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Hematologic Neoplasms
1
Hemangioma, Cavernous, Central Nervous System
1
Hemangioma, Cavernous
1
Ganglioneuroblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Carcinoma, Renal Cell
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Carboplatin
11
pembrolizumab
10
Paclitaxel
10
Fluorouracil
9
Oxaliplatin
8
Radiotherapy
7
Nivolumab
7
Leucovorin
6
Cisplatin
6
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Taxes
4
durvalumab
3
Trastuzumab
3
Surgical Procedures, Operative
3
Capecitabine
3
relatlimab
2
Standard of Care
2
Specimen Handling
2
Radiation
2
Proton Therapy
2
Practice Guidelines as Topic
2
Irinotecan
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Cetuximab
2
Blood Specimen Collection
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Neoplasms
×
Watchful Waiting
×
Clear all
NCT05953181
2024-09-19
SANO
Erasmus Medical Center
Phase NA
Active not recruiting
776 enrolled